Lighthouse Investment Partners’s United Therapeutics UTHR Stock Holding History

Lighthouse Investment Partners’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.87M	Buy	+3,446	New	+$1.94M	0.05%	377
2026 Q1	–	Sell	-3,500	Closed	-$1.74M	–	1076
2025 Q4	$1.71M	Sell	3,500 -278	-7%	-$129K	0.05%	383
2025 Q3	$1.58M	Buy	+3,778	New	+$1.27M	0.05%	370
2024 Q4	–	Sell	-671	Closed	-$240K	–	651
2024 Q3	$240K	Sell	671 -20,447	-97%	-$6.91M	0.01%	410
2024 Q2	$6.73M	Buy	+21,118	New	+$5.59M	0.27%	107
2023 Q1	–	Sell	-7,577	Closed	-$2.11M	–	384
2022 Q4	$2.11M	Buy	+7,577	New	+$1.91M	0.23%	88

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Lighthouse Investment Partners's UTHR Position: Q2 2026 in Review

Lighthouse Investment Partners opened a new position in United Therapeutics (UTHR) in Q2 2026: 3,446 shares worth $1.87M. The stake represents 0.05% of the portfolio and ranks #377 among its holdings. This is a return to the name: Lighthouse Investment Partners previously reported a position in UTHR as recently as Q4 2025.

Lighthouse Investment Partners first reported a position in UTHR in Q4 2022 and has held it in 6 quarters since. The position peaked at $6.73M in Q2 2024. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Lighthouse Investment Partners held 3,446 shares of United Therapeutics worth $1.87M as of Q2 2026.
United Therapeutics was a new Lighthouse Investment Partners position in Q2 2026.
United Therapeutics made up 0.05% of Lighthouse Investment Partners's portfolio in Q2 2026, its #377 holding.
Lighthouse Investment Partners first reported a position in United Therapeutics in Q4 2022 and has held it in 6 quarters since.
Lighthouse Investment Partners's United Therapeutics position peaked at $6.73M in Q2 2024.
878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Lighthouse Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.